Author’s Accepted Manuscript Nimotuzumab: beyond the EGFR signaling cascade inhibition Zaima Mazorra, Lisset Chao, Anabel Lavastida, Belinda Sanchez, Mayra Ramos, Normando Iznaga, Tania Crombet PII: S0093-7754(18)30041-1 DOI: https://doi.org/10.1053/j.seminoncol.2018.04.008 Reference: YSONC52055 To appear in: Seminars in Oncology Cite this article as: Zaima Mazorra, Lisset Chao, Anabel Lavastida, Belinda Sanchez, Mayra Ramos, Normando Iznaga and Tania Crombet, Nimotuzumab: beyond the EGFR signaling cascade inhibition, Seminars in Oncology,doi:10.1053/j.seminoncol.2018.04.008 This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting galley proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. image www.elsevier.com/locate/bios